#132: BIPH News CORRECTING and REPLACING Biophan Highlights First Quarter 2006 Milestones in Quarterly Report; Provides Update on Strategic Initiatives Including MYO-VAD(TM), Technology Licenses, and Partnerships
ROCHESTER, N.Y.--(BUSINESS WIRE)--July 11, 2006--Please replace the release dated July 10, 2006 with the following corrected version due to multiple revisions. The corrected release reads:...
#131: BIPH News Biophan meldet Bewilligung für neuen staatlichen Zuschuss über 1 Mio. USD zugunsten von MYOTECHs MYO-VAD(TM); zusätzliche 309.000 USD für staatlich bezuschusste Betriebsmittel zugunsten der Forschung von Biophan
ROCHESTER, N.Y.--(BUSINESS WIRE)--30. Juni 2006--Biophan Technologies, Inc. (OTCBB:BIPH) (FWB:BTN), ein Unternehmen, das medizinische Technologie der nächsten Generation entwickelt, meldete heute,...
#130: BIPH News Biophan Announces $1 Million Allocation in New Government Grants in Support of MYOTECH's MYO-VAD(TM); Plus $309,000 in Government Funded Equipment Provided in Support of Biophan Research
ROCHESTER, N.Y.--(BUSINESS WIRE)--June 29, 2006--Biophan Technologies, Inc. (OTCBB:BIPH) (FWB:BTN), a developer of next-generation medical technology, announced today the allocation this week of $1...
#128: BIPH News Biophan Europe Reports 2005 Development Milestones; Biophan Technologies' German Subsidiary Continues to Advance in Enabling Crucial MRI Visualization for Range of Medical Devices
ROCHESTER, N.Y.--(BUSINESS WIRE)--Dec. 28, 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, announced today that Biophan Europe GmbH...
ROCHESTER, N.Y.--(BUSINESS WIRE)-28. Dez. 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), ein Entwickler biomedizinischer Technologie der nächsten Generation meldete heute, dass die...
#126: BIPH News Biophan Announces Appointment of Former Genencor Executive Darryl L. Canfield to Post of Chief Financial Officer; Current CFO Robert J. Wood to Move to Consulting Capacity in January
ROCHESTER, N.Y.--(BUSINESS WIRE)--Dec. 19, 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, announced today the retirement of Robert...
ROCHESTER, N.Y.--(BUSINESS WIRE)-19. Dez. 2005-Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), ein Entwickler biomedizinischer Technologie der nächsten Generation, meldete heute, dass Robert...
ROCHESTER, N.Y.--(BUSINESS WIRE)--8. Dez. 2005-- Unternehmen beschreibt Pläne zur Verwendung von Finanzmitteln in Zusammenhang mit der Akquisitionsvereinbarung mit MYOTECH Biophan...
#123: BIPH News Biophan Announces Acceleration of Commercialization of MYO-VAD(TM) Cardiac Assist Device; Company Details Plans for Utilization of Funds to Be Invested In MYOTECH Under Acquisition Agreement
ROCHESTER, N.Y.--(BUSINESS WIRE)--Dec. 8, 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, today announced the acceleration of the...
ROCHESTER, N.Y.--(BUSINESS WIRE)-8. Dez. 2005 - Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), ein Entwickler biomedizinischer Technologie der nächsten Generation, kündigte heute, nach der...
#121: BIPH News Biophan Acquires Equity Stake in MYOTECH to Accelerate Commercialization of Breakthrough Cardiac Assist Device Technology; Purchase Agreement Provides Biophan Opportunity to Participate in Additional High Growth Markets
ROCHESTER, N.Y.--(BUSINESS WIRE)--Dec. 2, 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, announced today it has entered into a...
ROCHESTER, N.Y.----2. Dez. 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), ein Entwickler biomedizinischer Technologie der nächsten Generation, hat einen Kaufvertrag zur Übernahme eines...
#120: BIPH News Biophan meldet Erteilung zwei neuer Patente zur weiteren Expansion der technologischen Führungsposition in zentralen globalen Segmenten der biomedizinischen Industrie
ROCHESTER, N.Y.--(BUSINESS WIRE)--1. Dezember 2005-- Unternehmensportfolio an geistigem Eigentum umfasst damit insgesamt 212 erteilte und angemeldete Patente weltweit Biophan...
#118: BIPH News Biophan Announces Issuance of Two New Patents to Further Expand Technology Lead in Key Global Biomedical Industry Segments; Company's Intellectual Property Portfolio Now Totals 212 Patents Issued and Pending Worldwide
ROCHESTER, N.Y.--(BUSINESS WIRE)--Nov. 30, 2005--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation biomedical technology, announced today the issuance of two new...
#119: BIPH News Biophan meldet Erteilung zwei neuer Patente zur weiteren Expansion der technologischen Führungsposition in zentralen globalen Segmenten der biomedizinischen Industrie
ROCHESTER, N.Y.--(BUSINESS WIRE)-30. Nov. 2005-Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), ein Entwickler biomedizinischer Technologie der nächsten Generation, meldete heute die Erteilung...
